Jan 27, 2026
418:309
For every 309 shares held, investors received 418. The price per share adjusted from $20.90 to $15.45.
The split itself did not change the total investment value.
Dr. Lalchandani Labs Ltd. (BSE:DLCL) operates in the Medical/Nursing services industry.
Dr. Lalchandani Labs Ltd. company overviewDr. Lalchandani Labs Ltd.'s most recent stock split was on January 27, 2026. It was a 418-for-309 forward split, so shareholders received 418 shares for every 309 they held.
Dr. Lalchandani Labs Ltd. has split its stock once. This history records one forward split, on January 27, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Dr. Lalchandani Labs Ltd.'s 418-for-309 split on January 27, 2026, every 309 shares became 418 shares.
Dr. Lalchandani Labs Ltd. has not announced a new split in our records. Its most recent split was on January 27, 2026, less than a year ago. Companies announce splits in advance, and any new BSE:DLCL split will appear on this page.
Already premium?